Talaris Therapeutics, Inc. Common Stock

TALS

...

TALS: Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.

Show TALS Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of TALS by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by TALS's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on TALS's company Twitter account

WallStreetBets

Number of mentions of TALS in WallStreetBets Daily Discussion

TALS News

Recent insights relating to TALS

CNBC Recommendations

Recent picks made for TALS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TALS

Corporate Flights

Flights by private jets registered to TALS